Researchers at Aalto University and University of Turku have revealed how obesity is associated with altered opioid neurotransmission in the brain. New research reveals how obesity is associated with altered functioning of brain’s opioid system, which is intimately involved in generating pleasurable sensations.
The researchers measured availability of mu-opioid and type 2 dopamine receptors in normal-weight and obese individuals’ brains using positron emission tomography at the Turku PET Centre. The study is published in The Journal of Neuroscience.
The team found that obesity was associated with significantly lowered number of opioid receptors in the brain. However, no changes were observed in the dopamine neurotransmitter system, which regulates motivational aspects of eating.
Obesity is a great challenge to human health worldwide because it is associated with serious medical conditions such as type 2 diabetes, coronary heart disease, and stroke. Even though it is well known that unhealthy eating habits are the major cause for obesity, people have often problems with restraining their eating.
The team state that the findings highlight how obesity is associated with brain-level molecular changes. It is possible that the lack of brain’s opioid receptors predisposes obese individuals to overeating to compensate decreased hedonic responses in this system.
The researchers explain that the findings have major implications for understanding of the causes of obesity. They help to understand the mechanisms involved in overeating, and provide new insight into behavioural and pharmacological treatment and prevention of obesity. However, the group stress that they do not yet know whether the altered brain neurochemistry is a cause or consequence of obesity.
Source: Aalto University
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.